Xiaodan Mao

1.1k total citations
60 papers, 754 citations indexed

About

Xiaodan Mao is a scholar working on Molecular Biology, Epidemiology and Surgery. According to data from OpenAlex, Xiaodan Mao has authored 60 papers receiving a total of 754 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 19 papers in Epidemiology and 13 papers in Surgery. Recurrent topics in Xiaodan Mao's work include Cervical Cancer and HPV Research (15 papers), Genital Health and Disease (12 papers) and Endometrial and Cervical Cancer Treatments (9 papers). Xiaodan Mao is often cited by papers focused on Cervical Cancer and HPV Research (15 papers), Genital Health and Disease (12 papers) and Endometrial and Cervical Cancer Treatments (9 papers). Xiaodan Mao collaborates with scholars based in China, Germany and Australia. Xiaodan Mao's co-authors include Pengming Sun, Binhua Dong, Guanyu Ruan, Arthur J. Lustig, Huifang Lei, Jalid Sehouli, Yiyi Song, Pingping Su, Elena Ioana Braicu and Meimei Huang and has published in prestigious journals such as Analytical Chemistry, Scientific Reports and Genetics.

In The Last Decade

Xiaodan Mao

56 papers receiving 743 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaodan Mao China 16 349 211 138 103 97 60 754
Luz del Carmen Alarcón‐Romero Mexico 17 345 1.0× 245 1.2× 231 1.7× 63 0.6× 103 1.1× 53 744
Mark B. Van der Hoek Australia 16 412 1.2× 148 0.7× 306 2.2× 298 2.9× 59 0.6× 19 1.0k
Yu-Chih Wu Taiwan 13 355 1.0× 103 0.5× 198 1.4× 71 0.7× 75 0.8× 23 757
Canhui Cao China 16 443 1.3× 99 0.5× 229 1.7× 128 1.2× 72 0.7× 55 821
Miyuki Saito Japan 13 180 0.5× 373 1.8× 86 0.6× 98 1.0× 179 1.8× 25 690
Chih‐Ping Han Taiwan 15 271 0.8× 125 0.6× 123 0.9× 68 0.7× 93 1.0× 45 658
Haijun Yang China 17 487 1.4× 148 0.7× 293 2.1× 56 0.5× 312 3.2× 68 989
Weiming Zhao China 17 459 1.3× 140 0.7× 152 1.1× 124 1.2× 38 0.4× 43 761
Elizabeth Nugent United States 16 222 0.6× 295 1.4× 75 0.5× 25 0.2× 228 2.4× 41 930
Laurie Burdett United States 17 448 1.3× 167 0.8× 128 0.9× 106 1.0× 95 1.0× 29 840

Countries citing papers authored by Xiaodan Mao

Since Specialization
Citations

This map shows the geographic impact of Xiaodan Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaodan Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaodan Mao more than expected).

Fields of papers citing papers by Xiaodan Mao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaodan Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaodan Mao. The network helps show where Xiaodan Mao may publish in the future.

Co-authorship network of co-authors of Xiaodan Mao

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaodan Mao. A scholar is included among the top collaborators of Xiaodan Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaodan Mao. Xiaodan Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Mao, Xiaodan, et al.. (2025). The effect of environmental credit rating on enterprise green development. International Review of Financial Analysis. 101. 104038–104038. 1 indexed citations
3.
Mao, Xiaodan, Qibin Wu, Pingping Su, et al.. (2025). Antagonism of estrogen-related receptor-α inhibits mitochondrial oxidative phosphorylation and reduces M2 macrophage infiltration in endometrial cancer. Journal for ImmunoTherapy of Cancer. 13(9). e012521–e012521.
4.
5.
6.
Ren, Yuan, Dabin Liu, Shuting Tang, et al.. (2024). Assessment of Immune Status in Patients with Mismatch Repair Deficiency Endometrial Cancer. Journal of Inflammation Research. Volume 17. 2039–2050. 1 indexed citations
7.
Su, Pingping, An Jian, Huifang Lei, et al.. (2022). Peripheral Blood Lymphocyte Subsets as a Risk Predictor of Patients with Endometrioid Endometrial Cancer. Journal of Inflammation Research. Volume 15. 6153–6163. 3 indexed citations
8.
Tong, Yao, Meimei Huang, Huifang Lei, et al.. (2022). ERRγ, a Novel Biomarker, Associates with Pathoglycemia of Endometrial Cancer to Predict Myometrial Invasion. Journal of Oncology. 2022. 1–11. 3 indexed citations
9.
Lei, Huifang, et al.. (2021). Systemic Immune-Inflammatory Index as a Predictor of Lymph Node Metastasis in Endometrial Cancer. Journal of Inflammation Research. Volume 14. 7131–7142. 33 indexed citations
10.
Tong, Yao, et al.. (2020). Coinfection of High-Risk Human Papillomavirus and Lower Genital Tract Pathogens in the Development of High-Grade Cervical Lesions. Canadian Journal of Infectious Diseases and Medical Microbiology. 2020. 1–8. 1 indexed citations
12.
Mao, Xiaodan, et al.. (2020). <p>Peripheral Blood Inflammatory-Immune Cells as a Predictor of Infertility in Women with Polycystic Ovary Syndrome</p>. Journal of Inflammation Research. Volume 13. 441–450. 33 indexed citations
13.
Tong, Yao, et al.. (2020). <p>Low Red Blood Cell Count as an Early Indicator for Myometrial Invasion in Women with Endometrioid Endometrial Carcinoma with Metabolic Syndrome</p>. Cancer Management and Research. Volume 12. 10849–10859. 5 indexed citations
14.
Mao, Xiaodan, Binhua Dong, Min Gao, et al.. (2019). <p>Dual targeting of estrogen receptor α and estrogen-related receptor α: a novel endocrine therapy for endometrial cancer</p>. OncoTargets and Therapy. Volume 12. 6757–6767. 16 indexed citations
15.
Wang, Xuechun, et al.. (2018). Effect of a synthetic inhibitor of urokinase plasminogen activator on the migration and invasion of human cervical cancer cells in vitro. Molecular Medicine Reports. 17(3). 4273–4280. 13 indexed citations
16.
Sun, Pengming, et al.. (2018). PCR-reverse dot blot human papillomavirus genotyping as a primary screening test for cervical cancer in a hospital-based cohort. Journal of Gynecologic Oncology. 30(3). e29–e29. 12 indexed citations
17.
Sun, Pengming, Xiaodan Mao, Min Gao, et al.. (2018). Novel endocrine therapeutic strategy in endometrial carcinoma targeting estrogen-related receptor &alpha; by XCT790 and siRNA. Cancer Management and Research. Volume 10. 2521–2535. 19 indexed citations
18.
Mao, Xiaodan, et al.. (2018). Clinical validation of the Cervista<sup>&reg;</sup>&nbsp;high-risk human papillomavirus test in Chinese women from Fujian province: a cross-sectional study. Therapeutics and Clinical Risk Management. Volume 14. 2243–2253. 2 indexed citations
19.
Ruan, Guanyu, et al.. (2018). Cervical cancer screening using the Cervista high-risk human papillomavirus test: opportunistic screening of a hospital-based population in Fujian province, China. Cancer Management and Research. Volume 10. 3227–3235. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026